Pulmonary hypertension is associated with increased post-lung transplant mortality risk in patients with chronic obstructive pulmonary disease - PubMed (original) (raw)
Pulmonary hypertension is associated with increased post-lung transplant mortality risk in patients with chronic obstructive pulmonary disease
Vikas K Singh et al. J Heart Lung Transplant. 2015 Mar.
Abstract
Background: Pulmonary hypertension associated with lung disease (PHLD) has been shown to be a predictor of disease severity and survival in patients awaiting lung transplantation. Little is known about the relationship of PHLD and survival after lung transplantation or how this may vary by disease. This study evaluated the effect of PHLD on 1-year survival after lung transplantation for patients with the 3 most common indications for transplantation: chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and cystic fibrosis (CF).
Methods: Organ Procurement and Transplantation Network data were obtained for all lung transplant recipients who received an allograft between May 2005 and June 2010. The relationship between PHLD and 1-year survival after lung transplantation for each diagnostic group was examined with Kaplan-Meier estimates and Cox regression. Covariates included in the model were those defined in the current Lung Allocation Score system post-transplant survival model, including age, serum creatinine, percentage predicted forced vital capacity, functional status, and mechanical ventilation use at time of transplant. The estimated relative risk was calculated using Poisson regression with robust error variance and adjustment for covariates.
Results: Sample sizes for COPD, IPF, and CF patients were 2,025, 2,304, and 866, respectively. The 1-year post-transplant survival for COPD patients with PHLD was 76.9% vs 86.2% for COPD patients without PHLD (p = 0.001). In multivariate Cox regression analysis COPD patients with PHLD had a 1.74 (95% confidence interval, 1.3-2.3) times higher risk of 1-year post-transplant mortality (p = 0.001). Similar analyses for IPF and CF diagnostic groups showed no significant difference in survival between patients with and without PHLD.
Conclusions: COPD patients with PHLD have increased post-transplant 1-year mortality. No significant difference was seen in patients with IPF or CF. Further studies to evaluate the potential mechanisms for this difference between diagnoses are needed.
Keywords: Pulmonary hypertension associated with lung disease; chronic obstructive pulmonary disease; cystic fibrosis; idiopathic pulmonary fibrosis; lung transplantation; survival.
Copyright © 2015 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Similar articles
- Changes in pulmonary artery pressure affect survival differently in lung transplant recipients who have pulmonary hypertension or chronic obstructive pulmonary disease.
O'Keefe KL, Kilic A, Pope-Harman A, Hayes D Jr, Kirkby S, Higgins RS, Whitson BA. O'Keefe KL, et al. Exp Clin Transplant. 2014 Aug;12(4):283-9. Exp Clin Transplant. 2014. PMID: 25095706 - Obese patients with idiopathic pulmonary fibrosis have a higher 90-day mortality risk with bilateral lung transplantation.
Gries CJ, Bhadriraju S, Edelman JD, Goss CH, Raghu G, Mulligan MS. Gries CJ, et al. J Heart Lung Transplant. 2015 Feb;34(2):241-6. doi: 10.1016/j.healun.2014.09.031. Epub 2014 Sep 28. J Heart Lung Transplant. 2015. PMID: 25447567 - Surgical therapy for chronic obstructive pulmonary disease.
Martinez FJ, Chang A. Martinez FJ, et al. Semin Respir Crit Care Med. 2005 Apr;26(2):167-91. doi: 10.1055/s-2005-869537. Semin Respir Crit Care Med. 2005. PMID: 16088435 Review. - Pulmonary hypertension in chronic lung diseases.
Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Vachiéry JL. Seeger W, et al. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036. J Am Coll Cardiol. 2013. PMID: 24355635 Review.
Cited by
- Impact of Pulmonary Hypertension on Posttransplant Survival of Patients With Pulmonary Fibrosis at High Altitude: A Prospective Cohort Study.
Varón-Vega F, J Telléz L, Tuta-Quintero E, Rincón A, Casas D, Rodriguez C, Mendoza D, Giraldo-Cadavid LF. Varón-Vega F, et al. Can Respir J. 2025 Feb 24;2025:1861990. doi: 10.1155/carj/1861990. eCollection 2025. Can Respir J. 2025. PMID: 40041616 Free PMC article. - Accuracy of echocardiography and chest tomography for pulmonary hypertension screening in patients awaiting lung transplantation.
Degani-Costa LH, Assis JP, Gonçalves PPP, Gushken F, Szarf G, Afonso Junior JE. Degani-Costa LH, et al. Einstein (Sao Paulo). 2021 Dec 20;19:eAO5710. doi: 10.31744/einstein_journal/2021AO5710. eCollection 2021. Einstein (Sao Paulo). 2021. PMID: 34932775 Free PMC article. - The Intersection of Pulmonary Hypertension and Solid Organ Transplantation.
Frost AE. Frost AE. Methodist Debakey Cardiovasc J. 2016 Oct-Dec;12(4 Suppl):10-13. doi: 10.14797/mdcj-12-4s1-10. Methodist Debakey Cardiovasc J. 2016. PMID: 28298957 Free PMC article. Review. - Accuracy of CT Pulmonary Artery Diameter for Pulmonary Hypertension in End-Stage COPD.
Mohamed Hoesein FA, Besselink T, Pompe E, Oudijk EJ, de Graaf EA, Kwakkel-van Erp JM, de Jong PA, Luijk B. Mohamed Hoesein FA, et al. Lung. 2016 Oct;194(5):813-9. doi: 10.1007/s00408-016-9926-8. Epub 2016 Jul 16. Lung. 2016. PMID: 27423782 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical